Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

NIH researchers identify potential new antiviral drug for COVID-19
NIH researchers identify potential new antiviral drug for COVID-19
The experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19, suggests a study of cell cultures by researchers at the National Institutes of Health.
NIH launches clinical trial of universal influenza vaccine candidate
NIH launches clinical trial of universal influenza vaccine candidate
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus stra...
AstraZeneca’s Lynparza reduces relapse, death in breast cancer patients
AstraZeneca’s Lynparza reduces relapse, death in breast cancer patients
AstraZeneca Plc’s (AZN.
Moderna partners with Thermo Fisher to scale up COVID-19 vaccine production
Moderna partners with Thermo Fisher to scale up COVID-19 vaccine production
Moderna Inc said on Tuesday it had entered into an agreement with Thermo Fisher Scientific for manufacturing and packaging its COVID-19 vaccine, as the U.
Aptamer Group and PinotBio collaborate to develop new therapeutic drug conjugates
Aptamer Group and PinotBio collaborate to develop new therapeutic drug conjugates
Aptamer Group Limited, the developer of Optimer™ Therapeutics, and PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, today announces that they have ente...
Merck and Sanofi’s First and Only Six-in-One Pediatric Combination Vaccine Now Available in the United States
Merck and Sanofi’s First and Only Six-in-One Pediatric Combination Vaccine Now Available in the United States
KENILWORTH, N.
MorphoSys to Buy Constellation Pharmaceuticals for $1.7 Billion
MorphoSys to Buy Constellation Pharmaceuticals for $1.7 Billion
MorphoSys AG Wednesday said it agreed to buy Constellation Pharmaceuticals Inc.
Janssen’s myeloma CAR T therapy cilta-cel demonstrates ‘sustained efficacy’
Janssen’s myeloma CAR T therapy cilta-cel demonstrates ‘sustained efficacy’
Janssen has reported new data for its B-cell maturation antigen (BCMA) directed CAR T therapy ciltacabtagene autoleucel (cilta-cel) in heavily pretreated relapsed/refractory multiple m...
Vietnam detects a suspected new coronavirus variant that's a hybrid of the UK and India strains
Vietnam detects a suspected new coronavirus variant that's a hybrid of the UK and India strains
(CNN).
Covid: China's Sinovac vaccine gets WHO emergency approval
Covid: China's Sinovac vaccine gets WHO emergency approval
The World Health Organization (WHO) has approved China's Sinovac Covid vaccine for emergency use.
Novartis Deal May Lead To Cellerys Sale
Novartis Deal May Lead To Cellerys Sale
Novartis has signed a collaboration agreement and option to acquire Cellerys, a Zurich-based startup conducting research on a therapy to fight multiple sclerosis (MS), the Swiss drugmaker anno...
Alkermes' Lybalvi gains FDA approval for schizophrenia, bipolar I disorder
Alkermes' Lybalvi gains FDA approval for schizophrenia, bipolar I disorder
Alkermes announced Tuesday the US approval of Lybalvi (olanzapine/samidorphan) for the treatment of adults with schizophrenia and bipolar I disorder.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand